Defining risk

When a case was identified, a full travel and contact history was taken, as well as a risk assessment of the initial contact. Persons considered high risk or direct contacts (as per the WHO guidelines)26 were isolated. Where someone was considered a high-risk contact by WHO definition, but had completed a course of vaccination with a WHO approved vaccine course, they were considered a moderate-risk contact. Where all protocols had been followed, including the wearing of filtering face piece (2/3) masks on flights with high-efficiency particulate absorbing filtration, persons within two rows in any direction in an asymptomatic individual were considered moderate-risk contacts. Persons on the same aircraft but not within two rows in any direction were considered low-risk contacts.

For the majority of events, participants required a minimum of one negative RT-PCR test prior to travelling to each tournament or on arrival. High-risk contacts were isolated for 10 days.27 If the host country permitted it, moderate-risk contacts received education regarding enhanced medical surveillance, had daily rapid antigen testing for 5days, with RT-PCR day 5, mandated mask use and access to outside space for work purposes only. Low-risk contacts typically received rapid antigen testing every 48 hours and RT-PCR testing on day 5.

Testing was performed using a nasopharyngeal and oropharyngeal swab taken by a trained professional. For events from 1 October onwards, persons were permitted to self-swab if they had completed in-person and online training regarding the conduct of rapid antigen testing. Each day, a symptom and contact history checklist (table 1) were performed prior to admission to the event. Pre-travel and pre-tournament testing, daily symptom and contact checks were tracked through an event accreditation and tracking application (RFID, London, UK). Abnormalities were followed up by the medical team.

Testing and processing

Testing was conducted by Cignpost Diagnostics (Farnborough, UK) on Co-Diagnostics (Salt Lake City, USA) platforms, or through established local laboratories. The CoDx reagent kits and thermocyclers were utilised and had the ability to detect virus with high sensitivity and specificity (>99%) and a limit of detection of 2.4 viral particles/µL. Typical turn around times and reporting were within 2–4hours of swabbing. Each test assessed target genes up to a cycle threshold (Ct) of 40 cycles. Viral levels below Ct 40 were considered positive. Indeterminate samples were repeated, where necessary. Cignpost diagnostics or local laboratories also provided rapid antigen testing, using Abbott PanBio (Berkshire, UK), Innova (California, USA) or SD Biosensor (Suwon, South Korea).18 Antibody testing was not conducted systematically on DP World Tour. Contact tracing was conducted in line with WHO and local public health guidelines/requirements, with each contact informed and appropriate action taken.26

Contacts

There were 163 persons who were declared a ‘contact’ and met the host national public health guidelines for contact tracing (table 2). Of these, 11 were stratified as ‘high risk’, due to sustained indoor contact (shared hotel room, shared prolonged contact at residential address, shared meal at 1m for >1-hour indoors), without sufficient mitigation. Two (18%) of these subsequently tested positive for SARS-CoV-2. There were 79 moderate-risk contacts and 73 low-risk contacts. One moderate-risk contact (1%) subsequently tested positive for SARS-CoV-2 but did not transmit the virus. All other contacts remained negative.

Table 2

DP World Tour events following resumption of the 2021 season, with host nation COVID-19 incidence

Event	Location	Players (n=)	Date of event	National daily COVID-19 incidence per 100000 of population
Gran Canaria Lopesan Open	Gran Canaria, Spain	151	22–25 Apr 2021	18.4
Tenerife Open	Tenerife, Spain	151	29–2 May 2021	17.7
Canary Islands Championship	Tenerife, Spain	131	6–09 May 2021	14.9
Betfred British Masters	Sutton Coldfield, England	156	12–15 May 2021	3.4
Made in Himmerland	Farso, Denmark	156	27–30 May 2021	16.8
Porsche European Open	Hamburg, Germany	153	5–07 Jun 2021	3.8
BMW International Open	Munich, Germany	156	24–27 Jun 2021	1
Dubai Duty Free Irish Open	Co. Kilkenny, Ireland	155	1–4 July 2021	7.7
Abrdn Scottish Open	North Berwick, Scotland	156	8–11 July 2021	40.8
The Open Championship	Kent, England	156	15–18 July 2021	54.4
Cazoo Open	City of Newport, Wales	133	22–25 July 2021	13.2
ISPS HANDA World Invitational	Co. Antrim, Northern Ireland	143	29–1 August 2021	41.9
Hero Open	Fife, Scotland	143	05–8 August 2021	38
Cazoo Classic	Kent, England	144	12–15 August 2021	40.7
D+DReal Czech Masters	Prague, Czech Republic	124	19–22 August 2021	1.8
Omega European Masters	Crans Montana, Switzerland	156	26–29 August 2021	29.2
DS Automobiles Italian Open	Rome, Italy	156	2–5 September 2021	10.8
BMW PGA Championship	Surrey, England	144	9–12 September 2021	56.4
Dutch Open	Cromvoirt, Netherlands	144	16–19 September 2021	12.7
Alfred Dunhill Links Championship	Fife, Scotland	168	30–03 October 2021	50.6
ACCIONA Open de Espana	Madrid, Spain	132	07–10 October 2021	3.7
Estrella Damm N.A. Andalucia Masters	Sotogrande, Spain	126	14–17 October 2021	3.3
Mallorca Golf Open	Balearic Islands, Spain	120	21–24 October 2021	4
Portugal Masters	Vilamoura, Portugal	108	4–7 November 2021	8.3
AVIV Dubai Championship	Dubai, UAE	114	11–14 November 2021	1
DP World Tour Championship	Dubai, UAE	53	18–21 November 2021	1

Open in a separate window

High-risk exposure was typically shared indoor space (hotel room) or shared transport without completed vaccination course or wearing of personal protective equipment. Moderate-risk exposure was largely outdoor player-caddy encounters, outdoor interaction between event personnel, or shared outdoor meals at closer than 2 m, or high-risk exposure where a course of vaccination had been completed. Further contacts were established in off-site personnel including through contact tracing of airlines in collaboration with the host public health authority. It is estimated by the DP World Tour executives and medical team that the use of the risk assessment and risk reduction approach prevented the postponement or cancellation of three events during the 2021 season.

The number of players per event and local rates of COVID-19 at the time of the tournament can be seen in table 3. Local COVID-19 rates were reported on the date of the first day of the event. If this was not available, a weekly average was used. The mean number of daily cases per 100000 of the population across 26 events was 12.3 (SD 15.6). The full vaccination rate (as per WHO definition) of the included participants in this study was <20% at the beginning of the study (18 April 2021) and increased, to >94%when polled on 1 November 2021.

Table 3

Description of positive cases and contact risk by relevant events

	Cases (n=30)	Contact risk
		High (n=11)	Moderate (n=79)	Low (n=73)	Outcome of contacts
Gran Canaria Lospean Open	2	2	23	48	All contacts negative
Betfred British Masters	2	0	0	0	All contacts negative
Made in Himmerland	2	1	3	0	All contacts negative
Dubai Duty Free Irish Open	2	0	4	4	All contacts negative
Abrdn Scottish Open	2	0	4	0	All contacts negative
The Open Championship	4	3	9	5	1 high risk tested positive
ISPS HANDA World Invitational	1	1	3	0	All contacts negative
Hero Open	2	1	2	0	1 high risk tested positive
D+DReal Czech Masters	1	0	2	0	All contacts negative
Omega European Masters	2	1	5	0	All contacts negative
BMW PGA Championship	3	1	6	4	1 moderate risk positive
Dutch Open	0	0	0	3	All contacts negative
Alfred Dunhill Links Championship	3	0	9	5	All contacts negative
Portugal Masters	2	0	6	0	All contacts negative
AVIV Dubai Championship	2	1	3	4	All contacts negative

Open in a separate window

Discussion and comparison to the literature

This study has shown the successful scaling up of previous pilot work regarding a risk assessed and risk reduction approach to contact testing at professional golf events. At an international, multievent scale this protocol was shown to be effective in minimising the transmission of SARS-CoV-2 and allowing a significant number of players, caddies and staff to safely participate in events despite being COVID-19 contacts and otherwise having to self-isolate and miss events.

Professional sport has been required to be dynamic in its health protocols and strategies due to the evolving nature of the COVID-19 pandemic.6 With variations in international SARS-CoV-2 rates and policy responses, elite sport has been required to liaise closely with public health organisations and government to abide by differences in legalisation and ensure the safety of participants and staff as well as the wider population.5 Using the risk assessment and risk reduction approach in this study, the DP World Tour avoided the unnecessary isolation of 151 participants. The ability for persons to participate in these events was beneficial for them and for the events themselves. In addition, quarantine or isolation in foreign countries, distant to families and friends may have potential negative effects on mental and physical health. The DP World Tour chief medical officer and executives estimated that the protocol implemented in this study avoided the unnecessary postponement or cancellation of three events.

Comparison to literature

Initial modelling of testing schemes utilising daily lateral flow testing demonstrates an effective way of minimising viral transmission risk while maximising worker availability and isolation avoidance.30 A pilot scheme undertaken by Public Health England enabled contacts of positive cases to undergo daily lateral flow testing instead of adhering to the previous national guidance of isolation.31 In addition, a follow-up study showed 52% of those who tested positive would be more likely to share details of those they had been in contact with, if they knew daily testing would be implemented as opposed to self-isolation.32 These protocols are supported by recent evidence showing the recalibrated absolute sensitivity of lateral flow testing to be much higher than previous thought with values greater than 80%33 and this has been translated to a population level in Slovakia where rapid antigen screening was reported to have reduced COVID-19 incidence by 83%.34 Population data in England have shown lateral flow testing to be useful for identifying infections among asymptomatic adults, particularly those with high viral loads who are more likely to transmit the disease.35

In a randomised controlled trial of COVID-19 contacts at England secondary schools and colleges, the authors showed daily lateral flow testing to be non-inferior to self-isolation in regards to disease transmission, with similar rates of symptomatic infections in both groups.36 It was reported that daily lateral flow testing, reduced COVID-19-related school absences by 39%. With evolving knowledge of the benefits of daily lateral flow testing, the Department of Health and Social Care currently recommends daily lateral flow testing and additional cautions for the general population of England if a fully vaccinated person has been in contact with a person who is positive for COVID-19.37

The pilot study from the Gran Canaria Open 2021 demonstrated that a risk-assessed and risk reduction protocol was both feasible and effective in allowing a tournament to run safely while minimising the wider risk on a public health level to the host country.23 This strategy was scalable to a full season on the DP World Tour. Enhanced measures of hygiene for those not legally required to isolate were also encouraged in this study. On the DP World Tour this included, minimising shared indoor space, making attractive outdoor space available, mandating masks when indoors, and daily symptom and contact checking at arrival to events. Although there have been encouraging findings in both the pilot study and this study, other research has found daily antigen testing in collegiate athletes to be less effective, with false negative results leading to COVID-19 outbreaks.38

Colleagues at the World Health Organisation, and various international governing bodies for sport (ATP, FIFA, F1, the IOC, PGA Tour, and World Rugby) were instrumental in shaping risk assessment and risk mitigation policies. We thank Dr. Volker Scheer for his contribution to the data collection.